Walpar Nutrition

When is the next results date for Walpar Nutrition?

No Upcoming Board Meetings

What is the bonus history of the Walpar Nutrition?

Walpar Nutrition has announced a 1:1 bonus issue, with an ex-date and record date of August 14, 2024. Shareholders will receive one additional share for each share they own on that date.

Walpar Nutrition has announced a bonus issue with a ratio of 1:1. The ex-date for this bonus is set for August 14, 2024. This means that shareholders will receive one additional share for every share they currently own on that date. The record date for this bonus is also August 14, 2024. If you have any more questions about the company or its financial activities, feel free to ask!

Has Walpar Nutrition declared dividend?

No Dividend History Available

Who are the peers of the Walpar Nutrition?

Walpar Nutrition's peers include Hind. Unilever, ITC, Nestle India, and Britannia Inds., among others. Key insights show excellent management risk at ITC and Nestle India, with Choksi Asia leading in 1-year returns at 73.81%, while Walpar Nutrition has a 1-year return of 0.00%.

Peers: The peers of Walpar Nutrition are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Diana Tea Co, Choksi Asia, Jay Kailash, Kanco Tea, and Tapi Fruit.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Jay Kailash. Below Average management risk is noted at Diana Tea Co, Choksi Asia, Kanco Tea, and Tapi Fruit, and the rest. Growth is Good at Jay Kailash, Average at Nestle India, and Below Average at Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Diana Tea Co, Choksi Asia, Kanco Tea, and Tapi Fruit, and the rest. Excellent capital structure is seen at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, while Below Average capital structure is noted at Diana Tea Co, Choksi Asia, Jay Kailash, Kanco Tea, Tapi Fruit, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Choksi Asia at 73.81%, while the lowest is Godrej Consumer at -5.13%. Walpar Nutrition's 1-year return is 0.00%, which is lower than both the highest and lowest peers. Additionally, Diana Tea Co, Kanco Tea, and Tapi Fruit have negative six-month returns.

What is the technical trend for Walpar Nutrition?

As of June 4, 2025, Walpar Nutrition's trend is neutral with mixed signals, showing a shift from mildly bearish to sideways, as indicated by conflicting MACD readings and weak overall trend strength.

As of 4 June 2025, the technical trend for Walpar Nutrition has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating conflicting momentum. The RSI shows no signal on both weekly and monthly time frames, suggesting indecision. Daily moving averages are mildly bearish, contrasting with the weekly KST and Dow Theory, both of which are mildly bullish. The Bollinger Bands indicate a bullish trend on the weekly and a sideways trend on the monthly. Overall, the strength of the trend is weak, reflecting the sideways movement in price action and the lack of strong directional signals.

Who are in the management team of Walpar Nutrition?

As of March 2021, the management team of Walpar Nutrition includes Chairman & Managing Director Kalpesh Ladhawala, along with several Executive Directors and Independent Directors, responsible for the company's strategic direction and management.

As of March 2021, the management team of Walpar Nutrition includes the following individuals:<BR><BR>1. Kalpesh Pravinchandra Ladhawala - Chairman & Managing Director<BR>2. Tanmaykumar Ashwinbhai Shah - Whole-time Director<BR>3. Sejal Ladhawala - Executive Director<BR>4. Abhishekkumar Dineshkumar Patel - Executive Director<BR>5. Fenil Prakashkumar Sha - Executive Director<BR>6. Jigneshkumar Dineshkumar Modi - Executive Director<BR>7. Krunal Jashubhai Patel - Executive Director<BR>8. Nidhi YogeshKumar Shah - Executive Director<BR>9. Divyanshu Subhashchandra Raval - Executive Director<BR>10. Jayshukh Ramjibhai Detroja - Additional Non-Executive Director & Independent Director<BR>11. Rupesh Himatla Shah - Additional Non-Executive Director & Independent Director<BR>12. Tapan Natverlal Patel - Additional Non-Executive Director & Independent Director<BR>13. Nehalkumar Jasvantlal Shah - Additional Non-Executive Director & Independent Director<BR>14. Priyanka Shah - Company Secretary<BR>15. Megha Shah - Independent Director<BR><BR>This team is responsible for the strategic direction and management of the company.

What does Walpar Nutrition do?

Walpar Nutrition Ltd operates in the FMCG sector as a micro-cap company, originally founded in 2009 as "M/s Walpar Healthcare." It currently has no reported sales or profit data, with a market cap of INR 43 Cr and a P/E ratio of 27.00.

Overview: <BR>Walpar Nutritions Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is categorized as a micro-cap company.<BR><BR>History: <BR>Walpar Nutritions Ltd was originally incorporated as a Partnership Firm in 2009 under the name "M/s Walpar Healthcare." The partnership underwent several changes in its constitution on March 9, 2015, August 15, 2017, and June 12, 2020. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 43 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 27.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.01 <BR>Return on Equity: 12.67% <BR>Price to Book: 3.24<BR><BR>Contact Details: <BR>Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

Who are the top shareholders of the Walpar Nutrition?

The top shareholders of Walpar Nutrition include Kalpesh Pravinchandra Ladhawala with 18.36%, individual investors with 22.58%, and Xtended Business Reporting Limited as the largest public shareholder at 2.22%. There are no mutual funds or foreign institutional investors involved.

The top shareholders of Walpar Nutrition are primarily the promoters, with Kalpesh Pravinchandra Ladhawala holding the largest share at 18.36%. In addition to him, individual investors collectively own 22.58% of the company. The highest public shareholder is Xtended Business Reporting Limited, which holds 2.22%. There are currently no mutual funds or foreign institutional investors holding shares in the company.

How big is Walpar Nutrition?

As of 24th July, Walpar Nutrition Ltd has a market capitalization of 48.00 Cr, classifying it as a Micro Cap company, with no available financial data for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2024 shows Shareholder's Funds of 14.18 Cr and Total Assets of 37.10 Cr.

As of 24th July, <BR><BR>Market Cap: Walpar Nutritions Ltd has a market capitalization of 48.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 14.18 Cr and Total Assets valued at 37.10 Cr.

How has been the historical performance of Walpar Nutrition?

Walpar Nutrition has demonstrated significant growth from Mar'21 to Mar'25, with net sales increasing from 6.07 Cr to 71.76 Cr, and profit after tax rising from 0.15 Cr to 2.80 Cr, reflecting enhanced profitability and shareholder value. Total assets and liabilities have also grown proportionally, indicating a strong financial performance across various metrics.

Answer:<BR>The historical performance of Walpar Nutrition shows significant growth in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Walpar Nutrition's net sales have increased from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25, demonstrating a robust upward trend. The total operating income followed a similar trajectory, rising from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25. Raw material costs have also escalated, from 4.56 Cr in Mar'21 to 56.89 Cr in Mar'25, reflecting the company's expanding operations. Operating profit (PBDIT) has improved from 0.46 Cr in Mar'21 to 5.99 Cr in Mar'25, while profit before tax has surged from 0.16 Cr to 3.88 Cr during the same period. Profit after tax has risen from 0.15 Cr in Mar'21 to 2.80 Cr in Mar'25, indicating enhanced profitability. The earnings per share (EPS) have increased from 0.45 in Mar'21 to 2.47 in Mar'25, showcasing improved shareholder value. Total assets have grown from 17.97 Cr in Mar'21 to 47.39 Cr in Mar'25, while total liabilities increased from 17.97 Cr to 47.39 Cr, indicating a proportional growth in the company's financial structure. The cash flow from operating activities has remained positive, with a net cash inflow of 1.00 Cr in Mar'25 compared to previous years. Overall, Walpar Nutrition has shown a strong performance trajectory across various financial metrics over the years.

Is Walpar Nutrition overvalued or undervalued?

As of November 17, 2025, Walpar Nutrition is considered very attractive and undervalued with a PE ratio of 24.64 and an EV to EBITDA of 14.13, making it a more appealing investment compared to peers like Hindustan Unilever and Nestle India, despite a year-to-date return of -12.18% against the Sensex's 10.02%.

As of 17 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company is currently assessed as undervalued. Key ratios include a PE ratio of 24.64, an EV to EBITDA of 14.13, and a PEG ratio of 0.47, which suggests that the stock is priced favorably relative to its growth prospects.<BR><BR>In comparison to its peers, Walpar Nutrition stands out with its lower valuation metrics; for instance, Hindustan Unilever has a PE ratio of 53.89 and an EV to EBITDA of 38.18, while Nestle India shows a PE of 81.88. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Despite recent underperformance against the Sensex, with a year-to-date return of -12.18% compared to the Sensex's 10.02%, the company's strong fundamentals and favorable valuation ratios suggest potential for future growth.

Why is Walpar Nutritions Ltd falling/rising?

As of 02-Feb, Walpar Nutritions Ltd's stock price is at 45.50, unchanged from the previous day, and has declined 4.91% over the past week and month. The stock is underperforming its sector and has seen a significant drop in investor participation, indicating a negative outlook.

As of 02-Feb, Walpar Nutritions Ltd's stock price is currently at 45.50, showing no change from the previous day. The stock has experienced a decline of 4.91% over the past week and the same percentage over the past month. Year-to-date, the stock is down 4.91%, while it has decreased by 6.19% over the past year. In contrast, the Sensex has shown positive performance in the same periods, with a 0.16% increase over the last week and a 6.84% increase over the past year.<BR><BR>Today's performance indicates that the stock has underperformed its sector by 0.63%. Additionally, the stock's moving averages reveal that it is higher than the 50-day and 100-day moving averages but lower than the 5-day, 20-day, and 200-day moving averages, suggesting mixed signals regarding its short-term performance. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 28.57% against the 5-day average, which may indicate reduced interest from investors.<BR><BR>Overall, the combination of negative returns compared to the benchmark, underperformance in today's sector, and declining investor participation contributes to the perception that Walpar Nutritions Ltd's stock is currently falling.

Which are the latest news on Walpar Nutrition?